Sponsor Pipeline

Annovis Bio Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
3
Phase 3
3
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-11 NCT07757204 An Open-label Long-term Safety Study of Buntanetap in Participants With AD Phase 2/3 Not Yet Recruiting
Active Trials by Phase
Phase 3
1
Phase 2/3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06709014 A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants… Early Alzheimers Disease Active, Not Recruiting
Phase 2/3
NCT07284784 A Study of Buntanetap in Participants With PD Parkinson's Disease (PD) Recruiting
NCT07757204 An Open-label Long-term Safety Study of Buntanetap in Participants With AD Alzheimer's Dementia (AD) Not Yet Recruiting
Disease Areas
Alzheimer's Disease (2) Parkinson's Disease (1) Dementia (1)
Get alerts when Annovis Bio Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free